The next time you get bloodwork, ask your doctor to add ApoB to the panel.
ApoB stands for apolipoprotein B, the protein wrapped around every atherogenic lipoprotein particle in your bloodstream. One ApoB molecule per particle, so ApoB gives you the count.
Standard LDL-C measures the cholesterol cargo inside those particles, not how many particles there are.
Two women can have identical LDL-C numbers with very different ApoB counts. The one with more particles carries higher cardiovascular risk regardless of what her LDL-C says.
This discordance is not rare. Research suggests roughly one in five adults has a meaningful gap between LDL-C and particle number, with insulin resistance and postmenopausal lipid shifts making it more common in women over fifty.
Multiple analyses, including work published in JAMA Cardiology, have found ApoB more strongly associated with incident coronary heart disease than LDL-C or non-HDL-C. The European Society of Cardiology and the National Lipid Association now recommend ApoB as a primary or co-primary target for cardiovascular risk assessment.
For women in perimenopause and beyond, falling estrogen tends to push LDL particles toward smaller, denser, more numerous forms. LDL-C can stay flat while particle count climbs.
The ask is simple. Tell your doctor you want ApoB added to your next lipid panel.
It typically runs around thirty to fifty dollars at major labs and does not require fasting.
Recent National Lipid Association guidance points to roughly under 90 mg/dL for primary prevention, with tighter targets for women with established cardiovascular risk, diabetes, or elevated Lp(a). Your number, your family history, and your other markers determine what optimal looks like for you.
LDL-C is a proxy. ApoB is a count.
At fifty-plus, you want the count.
